Hyaluronic acid turnover controls the severity of cerebral cavernous malformations in bioengineered human micro-vessels.
Yordanov TE, Keyser MS, Enriquez Martinez MA, Esposito T, Tefft JB, Morris EK, Labzin LI, Stehbens SJ, Rowan AE, Hogan BM, Chen CS, Lauko J, Lagendijk AK.
Yordanov TE, et al. Among authors: rowan ae.
APL Bioeng. 2024 Feb 12;8(1):016108. doi: 10.1063/5.0159330. eCollection 2024 Mar.
APL Bioeng. 2024.
PMID: 38352162
Free PMC article.